The US Food and Drug Administration (FDA) has approved an injectable form of dantrolene sodium (Ryanodex, Eagle Pharmaceuticals) for rapid treatment of malignant hyperthermia (MH), along with the ...

A marketing authorization should be given for orphan medicine Agilus (dantrolene sodium, hemiheptahydrate) for the treatment of malignant hyperthermia, the European Medicines Agency (EMA) has said.

Malignant hyperthermia crises come on suddenly, and healthcare providers have no real way to predict which patients may experience this reaction while under anesthesia unless they have found a ...

Malignant hyperthermia (MH) is a life‐threatening pharmacogenetic disorder of skeletal muscle characterised by a hypermetabolic response to certain anaesthetic agents. Research in this field has ...

Malignant hyperthermia is an uncommon disorder that presents in an ambulatory surgery center utilizing general anesthesia. Preparation for management of this condition needs to be a significant part ...

Putting tubes into Sydnie Adams' ears should have been a simple procedure. The then-18-month-old La Crosse girl suffered from chronic ear infections. Doctors thought inserting tiny tubes would drain ...

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the ESHO-BSD Award for 2013 was awarded to Dr. Rüdiger Wessalowski in recognition ...

Early in the course of the development of these agents, haloperidol was found to cause not only hypokinetic and hyperkinetic motor disorders but also a potentially fatal syndrome of muscle rigidity ...